SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Karel Allegaert, Johannes N. Anker, Adverse drug reactions in neonates and infants: a population-tailored approach is needed, British Journal of Clinical Pharmacology, 2015, 80, 2
  2. You have free access to this content2
    Mark A. Turner, Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct, British Journal of Clinical Pharmacology, 2015, 79, 3
  3. 3
    K. Arunvikram, Ipsita Mohanty, K. K. Sardar, S. Palai, G. Sahoo, R. C. Patra, Adverse drug reaction and toxicity caused by commonly used antimicrobials in canine practice, Veterinary World, 2014, 7, 5, 299

    CrossRef

  4. 4
    Daniel B Hawcutt, Olya O’Connor, Mark A Turner, Adverse drug reactions in neonates: could we be documenting more?, Expert Review of Clinical Pharmacology, 2014, 7, 6, 807

    CrossRef

  5. 5
    Karel Allegaert, Tailored tools to improve pharmacotherapy in infants, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 8, 1069

    CrossRef

  6. 6
    Lateef Mohiuddin Khan, Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay – a systematic review, European Journal of Clinical Pharmacology, 2013, 69, 12, 1985

    CrossRef

  7. 7
    Karel Allegaert, Jean Paul Langhendries, John N. van den Anker, Educational paper: Do we need neonatal clinical pharmacologists?, European Journal of Pediatrics, 2013, 172, 4, 429

    CrossRef

  8. 8
    Michael Rieder, New Ways to Detect Adverse Drug Reactions in Pediatrics, Pediatric Clinics of North America, 2012, 59, 5, 1071

    CrossRef